Trends in Parasitology
Volume 29, Issue 1, January 2013, Pages 26-34
Journal home page for Trends in Parasitology

Review
Monocytes and macrophages in malaria: protection or pathology?

https://doi.org/10.1016/j.pt.2012.10.002Get rights and content

Recruitment and activation of monocytes and macrophages are essential for clearance of malaria infection, but these have also been associated with adverse clinical outcomes. In this review we discuss recent discoveries on how distinct molecular interactions between monocytes, macrophages, and malaria parasites may alter the balance between protection and pathology in malaria-infected individuals. The immunopathology of severe malaria often originates from excessive immune activation by parasites. The involvement of monocytes and macrophages in these events is highlighted, and priorities for future research to clarify the roles of these cells in malaria are proposed. Knowledge of the factors influencing the balance between protection and pathology can assist in the design of therapeutics aimed at modulating monocyte and macrophage functions to improve outcomes.

Section snippets

Monocytes, macrophages, and malaria

Whether an individual develops asymptomatic, mild, or severe malaria is partly dependent upon the balance between protective immunity and immunopathology. However, the factors that drive host immunity towards either protection or pathology, contributing to differential susceptibility and response to malaria, are not well understood. A comprehensive understanding of how host immune components interact with Plasmodium spp. malaria parasites may assist improved management and the design of novel

Monocyte/mac activation by parasite components in malaria erythrocytic stages

Various parasite components can activate monocytes/macs, either directly or indirectly by first activating other host immune factors (Figure 1). After erythrocyte invasion by merozoites, major transformations are induced on the IE surface, including the insertion of parasite proteins [5] that can interact with receptors on the monocyte/mac surface 6, 7. Whole IEs, or microparticles from their plasma membrane (shown in mouse model) [8], are potent immunogens that can directly promote macrophage

Phagocytosis

Phagocytosis of IEs by monocytes/macs is an effective way of reducing parasitaemia. However, efficiencies of IE uptake may differ among individuals, resulting in varying degrees of protection and susceptibility to malaria. An important factor regulating the efficiency of monocyte/mac phagocytosis is the availability of opsonins. Opsonins, such as complement fragments and antibodies, bind to IEs to enhance their interaction with monocyte/mac phagocytic receptors (Figure 1). Complement-mediated

Immunopathology associated with monocytes/macs in malaria infection

Individuals who cannot effectively clear erythrocytic-stage malaria infection are at risk of progressing to severe disease. Recent studies suggesting a role for monocytes/macs in causing immunopathology in these individuals are discussed below, in the context of different manifestations of severe malaria.

Concluding remarks

Recent studies have demonstrated that monocytes/macs are involved in both protection and immunopathology during malaria infection. The level of protection afforded by monocytes/macs through phagocytosis, ADCI, and cytokine production may differ between individuals, depending upon various parasite and host genetic factors. Monocytes/macs can also contribute to severe malaria manifestations through accumulation in the microvasculature and via various effector responses that may disrupt host

Acknowledgements

C.C. is supported by a Melbourne International Research Scholarship (University of Melbourne), a Melbourne International Fee Remission Scholarship (University of Melbourne) and a Nossal Institute for Global Health Travel Scholarship (The Nossal Institute for Global Health). J.A.H. is a Senior Principal Research Fellow of the National Health and Medical Research Council (NHMRC). This work was supported in part by Project Grants from the Australian NHMRC to S.J.R. (70318) and P.B. (1003384).

References (85)

  • P. von Hundelshausen

    Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium

    Blood

    (2005)
  • I. Francischetti

    Does activation of the blood coagulation cascade have a role in malaria pathogenesis?

    Trends Parasitol.

    (2008)
  • A.J. Umbers

    Malaria in pregnancy: small babies, big problem

    Trends Parasitol.

    (2011)
  • A.L. Conroy

    Complement activation: a critical mediator of adverse fetal outcomes in placental malaria?

    Trends Parasitol.

    (2011)
  • W.R.J. Taylor

    Respiratory manifestations of malaria

    Chest

    (2012)
  • M.N. Wykes et al.

    What really happens to dendritic cells during malaria?

    Nat. Rev. Microbiol.

    (2008)
  • M. Mauduit

    Dendritic cells and the malaria pre-erythrocytic stage

    Immunol. Res.

    (2012)
  • S.E. Lindner

    Malaria parasite pre-erythrocytic infection: preparation meets opportunity

    Cell. Microbiol.

    (2011)
  • C.A. Moxon

    Malaria: modification of the red blood cell and consequences in the human host

    Br. J. Haematol.

    (2011)
  • J.A. Stoute

    Complement receptor 1 and malaria

    Cell. Microbiol.

    (2011)
  • L. Serghides

    Placental chondroitin sulfate A-binding malarial isolates evade innate phagocytic clearance

    J. Infect. Dis.

    (2006)
  • K.N. Couper

    Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation

    PLoS Pathog.

    (2010)
  • K.L. Silver

    Complement driven innate immune response to malaria: fuelling severe malarial diseases

    Cell. Microbiol.

    (2010)
  • J. Langhorne

    Immunity to malaria: more questions than answers

    Nat. Immunol.

    (2008)
  • G. Feng

    Antibodies to variant surface antigens of Plasmodium falciparum–infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy

    J. Infect. Dis.

    (2009)
  • A.E. Tebo

    Fcγ receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro

    Clin. Exp. Immunol.

    (2002)
  • J. Keen

    HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites

    PLoS Med.

    (2007)
  • Y.P. Shi

    Fcγ Receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project

    J. Infect. Dis.

    (2001)
  • F. Nimmerjahn et al.

    FcγRs in health and disease

  • L.C. Willcocks

    A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus

    Proc. Natl. Acad. Sci. U.S.A.

    (2010)
  • M. Clatworthy

    Systemic lupus erythematosus-associated defects in the inhibitory receptor FcRIIb reduce susceptibility to malaria

    Proc. Natl. Acad. Sci. U.S.A.

    (2007)
  • T.J. Aitman

    Malaria susceptibility and CD36 mutation

    Nature

    (2000)
  • K. Lee

    CD36 deficiency is frequent and can cause platelet immunization in Africans

    Transfusion (Paris)

    (1999)
  • C.M. Cserti-Gazdewich

    Plasmodium falciparum malaria and the immunogenetics of ABO, HLA, and CD36 (platelet glycoprotein IV)

    Vox Sang.

    (2010)
  • A.K. Boggild

    Use of peroxisome proliferator-activated receptor γ agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial

    Clin. Infect. Dis.

    (2009)
  • W.H. Tham

    Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand

    Proc. Natl. Acad. Sci. U.S.A.

    (2010)
  • P. Chimma

    A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria

    PLoS Pathog.

    (2009)
  • C.D. Galamo

    Anti–MSP1 block 2 antibodies are effective at parasite killing in an allele-specific manner by monocyte-mediated antibody-dependent cellular inhibition

    J. Infect. Dis.

    (2009)
  • L.R. Pratt-Riccio

    Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth

    Mem. Inst. Oswaldo Cruz

    (2011)
  • H. Bouharoun-Tayoun

    Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

    J. Exp. Med.

    (1995)
  • A. Jafarshad

    A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcγRII and FcγRIII

    J. Immunol.

    (2007)
  • F. Lunel et al.

    Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro

    Infect. Immun.

    (1989)
  • Cited by (0)

    View full text